Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis

There is limited evidence on the efficacy of lenvatinib in advanced hepatocellular carcinoma (HCC) patients. Aim of this meta-analysis was to compare lenvatinib and sorafenib as first-line treatment. Computerized bibliographic search was performed on main databases through November 2020. The primary...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Transl Res
Hlavní autoři: Facciorusso, Antonio, Tartaglia, Nicola, Villani, Rosanna, Serviddio, Gaetano, Ramai, Daryl, Mohan, Babu P, Chandan, Saurabh, Abd El Aziz, Mohamed A, Evangelista, Jessica, Cotsoglou, Christian, Ambrosi, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129234/
https://ncbi.nlm.nih.gov/pubmed/34017396
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky